Anti-myosin Va siRNA and skin depigmentation
The present invention relates to novel isolated siRNAs comprising a sense RNA strand and a complementary antisense RNA strand which together form an RNA duplex, characterized in that the sense RNA strand comprises a sequence which has at most one nucleotide that is distinct in relation to a fragment of 14 to 30 contiguous nucleotides of the nucleotide sequence of exon F of the gene encoding the myosin Va protein, and also to compositions comprising at least one such siRNA, and to the use of at least one such siRNA as a cosmetic or therapeutic agent for skin depigmentation.
1. An isolated siRNA comprising a sense RNA strand and a complementary antisense RNA strand which together form an RNA duplex, wherein the sense RNA strand comprises a sequence selected from the group consisting of SEQ ID NO:2, SEQ ID NO:3, and SEQ ID NO:4.
2. The siRNA according to claim 1 , wherein said sense strand comprises or consists of the nucleotide sequence SEQ ID NO:3.
3. An isolated siRNA comprising a sense RNA strand and a complementary antisense RNA strand which together form an RNA duplex, wherein said siRNA is a shRNA consisting of a single molecule of single stranded RNA in which two complementary portions are paired by Watson-Crick bonds and are linked covalently on one side by a hairpin type structure, wherein said shRNA comprises or consists of the sequence SEQ ID NO:17.
4. The siRNA according to claim 1 , wherein the sense and/or antisense RNA strands further comprises a 3′ overhang fragment of 2 to 4 natural or modified LNA type nucleotides.
5. The siRNA according to claim 1 , wherein the sense RNA strand and/or the antisense RNA strand comprise at least one chemical modification in their sugar portions, their nucleobase portions or their internucleotide backbone.
6. A cosmetic agent comprising the siRNA according to claim 1 .
7. A drug comprising the siRNA according to claim 1 .
8. A composition comprising at least one siRNA according to claim 1 and an acceptable carrier.
9. The composition according to claim 8 , which is administered topically.
10. The composition according to claim 8 , wherein it further comprises at least one depigmenting agent.
11. The siRNA according to claim 1 , wherein said sense strand comprises or consists of the nucleotide sequence SEQ ID NO:4.
12. The siRNA according to claim 1 , wherein said sense strand comprises or consists of the nucleotide sequence SEQ ID NO:2.
13. The siRNA according to claim 1 , wherein both complementary strands of said siRNA comprise the same 3′ overhang fragment of 2 nucleotides with the sequence “TT”.
14. A composition comprising at least one siRNA according to claim 13 and an acceptable carrier.